column
    Innovation Drives the Development of Children's Drugs, Science and Technology Safeguards the Safety of Children's Medication
    MIAO Jing, SHU Qiang
    2024, 41(24): 3435-3439. DOI: 10.13748/j.cnki.issn1007-7693.20243623
    Abstract PDF
    Research on Liver Injury Related to Azole Antifungals in Children Based on FAERS Database
    ZHU Zhengyi, NI Yinghua, GAO Peng, HUANG Lingfei, YANG Jufei, MIAO Jing
    2024, 41(24): 3440-3446. DOI: 10.13748/j.cnki.issn1007-7693.20242866
    Abstract PDF
    Construction of A Risk Prediction Model for Childhood Anti-tuberculosis Drug Induced Liver Injury Based on Machine Learning
    XIE Qinqin, JI Huanhuan, YANG Ya, GONG Meiling, JIA Yuntao
    2024, 41(24): 3447-3455. DOI: 10.13748/j.cnki.issn1007-7693.20242822
    Abstract PDF
    Analysis of Influencing Factors of Height Growth Disorder Caused by Long-term Use of Glucocorticoids in Pediatric Patients Glomerular Disease
    HUANG Lingfei, WU Yuanyuan, CHENG Jiaping, GAO Peng, LU Zhihong, MIAO Jing
    2024, 41(24): 3456-3461. DOI: 10.13748/j.cnki.issn1007-7693.20242965
    Abstract PDF
    Risk Signals for Neonatal Use of Poractant Alfa Based on FAERS Database Mining and Analysis
    LI Shanshan, SHEN Longhui
    2024, 41(24): 3462-3469. DOI: 10.13748/j.cnki.issn1007-7693.20242352
    Abstract PDF
    Taste Evaluation of Oral Solution of Carbocysteine for Children Based on Electronic Tongue Technology
    MEI Dong, ZHANG Huan, YOU Longtai, WU Xueping, HE Shuwang, WANG Xiaoling
    2024, 41(24): 3470-3474. DOI: 10.13748/j.cnki.issn1007-7693.20240426
    Abstract PDF
    Influencing Factors and Risk Prediction Model Construction of Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease
    YE Weifeng, WU Yuanyuan, SUN Jin, HUANG Lingfei, GAO Xiangbo, LUO Youyou
    2024, 41(24): 3475-3480. DOI: 10.13748/j.cnki.issn1007-7693.20242819
    Abstract PDF
    Screening and Verification of Therapeutic Drugs Targeting Anaplastic Lymphoma Kinase for Childhood Neuroblastoma
    LIU Tianyi, HU Xuejiao, ZHANG Zhe, HU Qingyang, YAN Wenxin, DONG Xue, LI Zhong
    2024, 41(24): 3481-3487. DOI: 10.13748/j.cnki.issn1007-7693.20242831
    Abstract PDF
    Therapeutic Drug Monitoring of Lacosamide in Epileptic Children’s Plasma Based on Isotope Dilution-UPLC-Q-Exactive-MS Method
    WU Jiaxuan, MA Yinghua, HU Shiyuan, ZHAO Yile, LIU Kang, DONG Lei
    2024, 41(24): 3488-3497. DOI: 10.13748/j.cnki.issn1007-7693.20233683
    Abstract PDF
    Research Progress on the Effectiveness, Safety, and Individualized Medication of Vigabatrin in Pediatric Patients with Infantile Spasms
    WANG Jie, GUO Hongli, ZHANG Yuanyuan, WU Chunfeng, LU Xiaopeng, CHEN Feng, XU Jin
    2024, 41(24): 3498-3505. DOI: 10.13748/j.cnki.issn1007-7693.20242720
    Abstract PDF
    Cost-effectiveness Analysis of Baloxavir Marboxil in the Treatment of Pediatric Influenza
    LIU Yangjun, TANG Yuxin, WANG Shuling
    2024, 41(24): 3506-3510. DOI: 10.13748/j.cnki.issn1007-7693.20240660
    Abstract PDF
    Research Advances in Small Molecule Targeted Drugs for Pediatric Neuroblastoma
    JIA Tingting, LIN Yan, ZHANG Meng, MIAO Jing
    2024, 41(24): 3511-3519. DOI: 10.13748/j.cnki.issn1007-7693.20242844
    Abstract PDF
    Research Progress of Janus Kinase Inhibitors in Childhood Diseases
    PAN Hongai, SHEN Yan, MIAO Jing
    2024, 41(24): 3520-3526. DOI: 10.13748/j.cnki.issn1007-7693.20242935
    Abstract PDF
    Research Advances in Therapeutic Application of FLT3 Tyrosine Kinase Inhibitors in Pediatric Acute Myeloid Leukemia
    ZHOU Ping, YAN Xiaomeng, FENG Kaiyuan
    2024, 41(24): 3527-3536. DOI: 10.13748/j.cnki.issn1007-7693.20243051
    Abstract PDF
    Exploring the Promoting Effect of Fu's Cupping Therapy on the "Water-Lipid" Binary Component of Salviae Miltiorrhizae Radix et Rhizoma Based on Microdialysis
    XIE Huan, ZHOU Bin, HE Jinying, XU Jian, LIU Yao, CAO Guoqiong, ZHANG Yongping
    2024, 41(24): 3537-3542. DOI: 10.13748/j.cnki.issn1007-7693.20233164
    Abstract PDF
    Mechanism of Action of Dabuyin Pill in IgA Nephropathy Mice Based on Nrf2/Keap1/HO-1 and P38MAPK/P53/P21 Pathways
    GU Yifan, HUANG Guodong, SU Yanlin, ZHANG Weipeng, CHEN Shuting
    2024, 41(24): 3543-3552. DOI: 10.13748/j.cnki.issn1007-7693.20240054
    Abstract PDF
    Research on the Anti-hyperlipidemia Effect and Mechanism of Linderae Folium via UFLC-MS/MS Combined with Network Pharmacology and Experimental Validation
    CAI Zhongqi, LUO Yiyuan, WANG Furong, LI Na, CAI Hongdie, CHEN Nini, CHEN Hongjiang, WANG Juan
    2024, 41(24): 3553-3564. DOI: 10.13748/j.cnki.issn1007-7693.20233166
    Abstract PDF
    Comparative Study of Antimicrobials for Children in China and WHO EMLc
    LI Xinyu, SHAO Rong, YAN Jianzhou
    2024, 41(24): 3565-3573. DOI: 10.13748/j.cnki.issn1007-7693.20233189
    Abstract PDF
    Risk Control Strategies for Clinical Trials of Drugs in Rheumatology and Immunology Department
    TANG Haofeng, HU Zishu, CHENG Guohua
    2024, 41(24): 3574-3580. DOI: 10.13748/j.cnki.issn1007-7693.20232188
    Abstract PDF